NuGen Medical Announces First Bulk Purchase Order for InsuJet(TM)
Toronto, Ontario--(Newsfile Corp. - June 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has received its first bulk purchase order from Science-Link Trading SAPI de CV ("Science-Link"), a company in Mexico, for the Mexican market for 500 units of the Company's needle-free InsuJet™ injector device. The initial bulk purchase order for the 500 InsuJet™ devices is to be pre-paid in full prior to delivery. NuGen is pleased to further report...
2023-06-02 5:15 PM EDT
NuGen Medical Devices to Hold Investor Lunch Presentation in Toronto, Ontario on June 15th, 2023
Toronto, Ontario--(Newsfile Corp. - May 30, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that it is hosting an investor lunch presentation on June 15th at Modus Restaurant, located at 145 King Street West, Toronto, Ontario M5H 1J8 at 12:00 p.m. EDT, limited to 70 attendees. "Maintaining the philosophy of treating our investors as customers, I cordially invite shareholders and interested parties to our Investor Lunch Presentation to be held on June...
2023-05-30 5:15 PM EDT
NuGen Medical Devices Announces Services Agreement
Toronto, Ontario--(Newsfile Corp. - May 29, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that, further to its press release dated February 28, 2023, it has entered into an amended and restated agreement (the "Agreement") dated May 29, 2023 with bullVestor Medien GmbH ("bullVestor"), an arm's-length party to the Company, to provide marketing services to the Company for a period ending in June 2023. The services will include the creation of content, strategic planning, digital...
2023-05-29 5:15 PM EDT
NuGen Medical Devices Announces Closing of $450,000 Non-Brokered Private Placement of Units
Toronto, Ontario--(Newsfile Corp. - May 18, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that it has closed a non-brokered private placement of units (the "Offering") through the issuance of 2,500,000 units (each a "Unit") at a price of $0.18 per Unit for aggregate gross proceeds of $450,000."As a result of strong demand, we elected to accommodate those that missed the cut-off date from our previous financing that closed April 25, 2023," commented Richard Buzbuzian,...
2023-05-18 12:36 PM EDT
NuGen Medical Devices Announces Closing of $4,000,000 Non-Brokered Private Placement of Units
Toronto, Ontario--(Newsfile Corp. - April 25, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that it has closed its non-brokered private placement of units (the "Offering") through the issuance of 22,222,222 units (each a "Unit") at a price of $0.18 per Unit for aggregate gross proceeds of $4,000,000. "Strong investor demand from new and existing shareholders has provided NuGen with the capital necessary to embark on the Company's next phase of growth. Our path to...
2023-04-25 5:40 PM EDT
NuGen Medical Devices Announces Upsize to Non-Brokered Private Placement of Units
Toronto, Ontario--(Newsfile Corp. - April 21, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") is pleased to announce that, further to its press release of March 31, 2023, its previously announced non-brokered private placement of units (each, a "Unit") at a price of $0.18 per Unit has been upsized to 22,222,222 Units for aggregate gross proceeds of $4,000,000 (the "Offering").Net proceeds raised from the Offering will be used for working capital and general corporate purposes.Each Unit consists of...
2023-04-21 3:40 PM EDT
NuGen Medical Commences Feasibility Study, Validation and Testing for Semaglutide - "Ozempic(R)"
Toronto, Ontario--(Newsfile Corp. - April 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces it has engaged Basic Pharma Technologies, a pharmaceutical company located in the Netherlands, to perform an assessment and feasibility study, which will include validation testing of semaglutide if administered using NuGen's needle free injection device, InsuJet™.Semaglutide is the drug known as Ozempic® and it is currently administered by a pen-needle method.Integrity testing of semaglutide being administered via InsuJet™ will be conducted...
2023-04-10 5:15 PM EDT
NuGen Medical to Hold Its First Ever Investor Night in Vaughan, Ontario
Toronto, Ontario--(Newsfile Corp. - April 4, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it is hosting its first Investors Presentation night in Vaughan, Ontario on April 20, 2023 at 7:00 p.m. EST."We have always maintained the philosophy of treating our Investor's as customers and cordially invite all interested parties to attend our event on April 20, 2023," commented Tony Di Benedetto, Executive Chairman. "We will be showcasing our Insujet™ platform and...
2023-04-04 8:30 AM EDT
NuGen Medical Appoints Louise Cresswell as Commercial Lead - United Kingdom
Toronto, Ontario--(Newsfile Corp. - April 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce the appointment of Louise Cresswell as the Commercial Lead for the United Kingdom. Ms. Cresswell has an extensive background working in the UK health sector both as a registered nurse and in commercial, sales and marketing roles with international manufacturers and suppliers of medical technologies. As Commercial Lead, Ms. Cresswell will be responsible for growth of NuGen's...
2023-04-03 5:15 PM EDT
NuGen Medical to Raise Up to $3.6 Million in Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces it intends to complete a non-brokered private placement of up to $3,600,000 through the issuance of up to 20,000,000 units (the "Units") in the capital of the Company at a price of $0.18 per Unit (the "Offering"). Gross proceeds of the Offering will be used for working capital and general corporate purposes. Each Unit consists of one common share (each, a...
2023-03-31 8:30 AM EDT
NuGen Medical Announces New Online B2C Subscription Business
Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce its new B2C online subscription-based business to be offered at www.insujet.com will be available to consumers in the coming weeks ahead.By utilizing fulfillment centers across Europe and Canada, we ensure fast delivery for all purchases that can be made via smartphone or our web shop with just a few clicks. The customer's starter kit is then picked, packed,...
2023-03-29 5:15 PM EDT
NuGen Medical Reports Distribution Business Boasts Margins of 70%+
Toronto, Ontario--(Newsfile Corp. - March 27, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report that the Company's InsuJet™ needle-free injection device is actively sold in 11 countries through NuGen's distributor and wholesale network.InsuJet™ will soon be readily provided to end-customers throughout Europe through conventional channels, such as pharmacies for patients who have a prescription for the device. The reusable nature of InsuJet™ and its consumables allow competitive prices compared with conventional needles...
2023-03-27 5:15 PM EDT
NuGen Medical Announces the Return of Veronique Laberge as Chief Financial Officer and Corporate Secretary
Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that the Board of Directors has re-appointed Ms. Veronique Laberge as Chief Financial Officer and Corporate Secretary of the Company. "I am excited to return into the CFO role at NuGen and work with the new management team to help the company continue executing its strategic plan, accelerate growth and deliver value to shareholders," commented Veronique Laberge. "On...
2023-03-10 5:15 PM EST
NuGen Medical's Needle-Free Injection Device, InsuJet(TM) Delivers Increased Efficacy of Insulin for Diabetic Patient Care
Toronto, Ontario--(Newsfile Corp. - March 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.Studies were performed at the Radboud University Medical Center in Nijmegen, Netherlands[2],[3] and were published in various influential medical journals including Diabetes Care. Many patients confirm they notice a faster...
2023-03-03 5:15 PM EST
NuGen Medical Announces the Appointment of Tony Di Benedetto as Executive Chairman and Director
Toronto, Ontario--(Newsfile Corp. - February 28, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that the Board of Directors has appointed Mr. Tony Di Benedetto as Executive Chairman and Director."I was approached by NuGen's new CEO, Richard Buzbuzian, who I had tremendous success with having built Drone Delivery Canada together from inception to then being named in 2021 the Best 50 top-preforming companies traded on the OTCQX Best Market. So, when Richard...
2023-02-28 5:15 PM EST
NuGen Medical Devices Inc. Announces the Appointment of Richard Buzbuzian as President, CEO and Director
Toronto, Ontario--(Newsfile Corp. - February 22, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") is pleased to announce that the Board of Directors has appointed Richard Buzbuzian as President, CEO and Director."InsuJet™, our needle-free injection device has tremendous sales opportunity globally and is approved for sale in 42 countries with active sales distribution agreements in 11. I look to complement our existing business with an expanded plan to monetize InsuJet sales with an ecommerce model, primarily B2C," commented...
2023-02-22 4:30 PM EST
NuGen Medical Devices Announces Closing of $2,500,000 Non-Brokered Private Placement of Units
Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") announces that it has closed its previously announced (see press release dated January 26, 2023) non-brokered private placement of units (the "Offering") through the issuance of 50,000,000 units (each a "Unit") at a price of $0.05 per Unit for aggregate gross proceeds of $2,500,000. Each Unit is comprised of one (1) common share in the capital of the Company ("Common Shares") and one (1)...
2023-02-14 5:15 PM EST
NuGen Medical Devices Announces New Unit Offering and Resignations and Appointment of An Officer and Director
Toronto, Ontario--(Newsfile Corp. - January 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") announces that it has closed its previously announced non-brokered private placement of units as described in its press release dated December 28, 2022 for total aggregate proceeds of $125,000. No additional tranches will be completed. The proceeds will be used by the Company for corporate and general working capital purposes.Further, the Company is pleased to announce a new non-brokered private placement financing (the...
2023-01-26 9:00 AM EST
NuGen Applies for Extension of Price Protection for Private Placement
Toronto, Ontario--(Newsfile Corp. - August 10, 2022) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") announces that in connection with the private placement (the "Offering") originally announced in the Company's press release of July 22, 2022, the Company has applied to the TSX Venture Exchange for an extension of a further 30 days price protection in order to complete further subscriptions. The Company intends the next tranche of the Offering to close in the next couple weeks.Further closing...
2022-08-10 11:47 AM EDT
NuGen Provides 2021 Year in Review and 2022 Corporate Update
Toronto, Ontario--(Newsfile Corp. - January 12, 2022) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to provide an overview of its 2021 accomplishments and its corporate objectives for 2022. NuGen would first like to thank our shareholders for their continued support as the Company completed the Qualifying Transaction and achieved its public listing on the TSX Venture Exchange (the "Listing"). The Company is working towards its objectives of becoming the global leader of needle-free injection...
2022-01-12 6:30 AM EST